News from NORD

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone

Publish date: April 14, 2017

 

The Foundation for Prader-Willi Research has published a blog and brochure regarding recent findings related to use of growth hormone for those affected by Prader-Willi syndrome.

Recommended Reading

NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Hematology and Oncology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Hematology and Oncology
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
MDedge Hematology and Oncology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Hematology and Oncology
NORD and Neurology Reviews Publish Special Report
MDedge Hematology and Oncology
Save the Date for the 2017 NORD Summit
MDedge Hematology and Oncology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Hematology and Oncology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Hematology and Oncology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Hematology and Oncology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Hematology and Oncology